Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular complications in patients receiving chemotherapy - what role do 3rd-generation antiemetics play.

Oncology reports·2011
Same author

Primary central benign encondroma of the ribs; clinical contribution.

Giornale italiano di chirurgia·2010
Same author

[Multimodal treatment of gastric MALT lymphoma: our experience].

I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]·2006
Same author

The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2004
Same author

Cross reactivity due to positive canrenone interference.

Gut·2004
Same author

Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2003

Related Experiment Video

Updated: Jul 3, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Liver-kidney pathophysiological interrelationships in liver diseases.

P Gentilini1, G La Villa

  • 1Department of Internal Medicine, University of Florence School of Medicine, Florence, Italy. p.gentilini@dfc.unifi.it

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
|July 16, 2008
PubMed
Summary

This study explores kidney and liver interactions, detailing how liver disease impairs renal function through hemodynamic changes, metabolic issues like renal tubular acidosis, and organic damage from immune responses.

More Related Videos

Steps for the Autologous Ex vivo Perfused Porcine Liver-kidney Experiment
10:15

Steps for the Autologous Ex vivo Perfused Porcine Liver-kidney Experiment

Published on: December 18, 2013

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

Related Experiment Videos

Last Updated: Jul 3, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Steps for the Autologous Ex vivo Perfused Porcine Liver-kidney Experiment
10:15

Steps for the Autologous Ex vivo Perfused Porcine Liver-kidney Experiment

Published on: December 18, 2013

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

Area of Science:

  • Nephrology
  • Hepatology
  • Internal Medicine

Background:

  • Kidney and liver relationships are complex, with renal function during liver disease being a key area of research.
  • Alterations in renal function due to liver disease manifest in several distinct ways.

Purpose of the Study:

  • To delineate the mechanisms of renal impairment in liver disease.
  • To categorize the different types of renal functional impairment observed.

Main Methods:

  • Review of clinical and experimental research on kidney-liver interactions.
  • Analysis of mechanisms including hemodynamic derangement, metabolic disturbances, and immunological responses.

Main Results:

  • Renal functional impairment involves hemodynamic changes (e.g., decreased peripheral vascular resistance, hyperdynamic circulation) leading to renal ischemia.
  • Metabolic damage includes tubular dysfunction and renal tubular acidosis (RTA), particularly type I, common in cholestatic disease.
  • Organic impairment arises from immune responses, with immunocomplexes and cryoglobulins depositing in glomeruli, triggering inflammation.

Conclusions:

  • Liver disease significantly impacts kidney function through multiple pathways.
  • Understanding these mechanisms is crucial for managing patients with co-existing liver and kidney conditions.
  • Further research into hepatorenal syndrome and associated renal pathologies is warranted.